Artelo Biosciences stock soars after announcing $9.5M private placement for Solana-based treasury

Published 04/08/2025, 12:36
© Reuters.

Investing.com -- Artelo Biosciences (NASDAQ:ARTL) stock surged 20% on Monday after the clinical-stage pharmaceutical company announced a $9.475 million at-the-market private placement to initiate a Solana-based treasury strategy.

The company said it has entered into a securities purchase agreement at a price of $10.45 per share, which includes common stock and warrants. According to the announcement, Artelo will become the first publicly-traded pharmaceutical company to adopt SOL, Solana’s native cryptocurrency, as a core reserve asset.

Lead investor Bartosz Lipiński, previously Head of Engineering at Solana Labs and recognized as the inventor of Metaplex, will serve as a technical partner through his company CUBE, which will secure storage, staking, and active DeFi execution of Artelo’s digital asset treasury.

"I am pleased to partner with Artelo for their groundbreaking SOL treasury initiative within the pharmaceutical industry," said Lipiński, who is now Co-Founder and CEO of Cube Group. "Solana’s unparalleled scalability and decentralized infrastructure make it a cornerstone of the future financial ecosystem."

The company’s board has approved plans to expand its SOL treasury management strategy over time while maintaining adequate working capital for its pharmaceutical development programs. This latest financing brings Artelo’s total proceeds from private placements since June 2025 to $10.9 million.

The transaction is expected to close around August 5, 2025, subject to customary closing conditions. R.F. Lafferty & Co. acted as an advisor for the private placement.

Artelo Biosciences focuses on developing treatments for cancer, pain, and dermatological or neurological conditions by modulating lipid-signaling pathways.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.